The Hospital of Central Connecticut — New Britain, Connecticut

Public research footprint of The Hospital of Central Connecticut, compiled from the ClinicalTrials.gov public registry.

227

Registered studies

Active

Recruiting now

121

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Clear Cell Adenocarcinoma · Recurrent Endometrial Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Hospital of Central Connecticut?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.